Živadinović R, Petrić A, Krtinić D, Stevanović Milosević J, Pop Trajković Dinić S
Clinic for Gynaecology and Obstetrics, Clinical Centre Nis, Serbia.
Faculty of Medicine, University of Nis, Serbia.
West Indian Med J. 2015 Jun;64(3):236-40. doi: 10.7727/wimj.2014.230. Epub 2015 Apr 8.
The objective of this study was to examine the validity of ascitic fluid cytology in the detection of pathological findings, to examine the percentage of false positive and false negative results in the cytology of ascitic fluid and to determine the validity of peritoneal cytology in relation to the histopathological type of the ovarian tumour.
This retrospective study included 170 peritoneal cytology findings. The study was conducted from January 2010 to December 2012. The experimental group included 76 cytology findings obtained from patients diagnosed with ovarian carcinoma, whereas the control group was composed of 94 cytology findings of benign ovarian tumours and liver cirrhosis ascites. The patients with ovarian carcinoma had grades III, as well as grades I and IIc but only in cases where operative and pathological finding indicated a ruptured or perforated tumour capsule.
The sensitivity of peritoneal cytology is 68.92%, specificity is 93.61%, positive predictive value is 89.65% and negative predictive value is 78.57%. In 30.02% of patients, the peritoneal cytology showed false negative results, while in 6.38%, the results were false positive. The highest percentage of false negative findings was 77%, found in endometrioid carcinoma.
Peritoneal cytology of ascitic fluid is highly specific but has relatively low sensitivity, particularly in the case of endometrioid ovarian carcinoma. In order to increase sensitivity, peritoneal cytology should be combined with monoclonal antibodies and other biochemical and immunohistochemical markers.
本研究的目的是检验腹水细胞学在检测病理结果方面的有效性,检查腹水细胞学假阳性和假阴性结果的百分比,并确定腹膜细胞学与卵巢肿瘤组织病理学类型的相关性。
这项回顾性研究纳入了170例腹膜细胞学检查结果。研究时间为2010年1月至2012年12月。实验组包括从诊断为卵巢癌的患者中获得的76例细胞学检查结果,而对照组由94例良性卵巢肿瘤和肝硬化腹水的细胞学检查结果组成。卵巢癌患者为III级,以及I级和IIc级,但仅限于手术和病理结果显示肿瘤包膜破裂或穿孔的病例。
腹膜细胞学的敏感性为68.92%,特异性为93.61%,阳性预测值为89.65%,阴性预测值为78.57%。在30.02%的患者中,腹膜细胞学显示假阴性结果,而在6.38%的患者中,结果为假阳性。假阴性结果的最高百分比为77%,见于子宫内膜样癌。
腹水的腹膜细胞学具有高度特异性,但敏感性相对较低,尤其是在子宫内膜样卵巢癌的情况下。为了提高敏感性,腹膜细胞学应与单克隆抗体及其他生化和免疫组化标志物联合使用。